Jon Moore
InvestorOperating Partner at Advent Life Sciences
About
Jon Moore joined Advent Life Sciences in 2018, bringing over two decades of experience at UK biotech companies, including a role as CSO of Horizon Discovery. His background covers early-stage drug discovery against first-in-class targets, gene editing applied to drug discovery, and therapeutic platform development. Since joining Advent he has focused on new company creation, serving as founding CEO of Pheno Therapeutics and currently as founding CEO of cancer immuno-therapeutics company Epitopea.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Investor
EpitopeaPheno Therapeutics
Per the firm's website.
Colleagues at Advent Life Sciences
Alain Huriez
Venture Partner at Advent Life Sciences
Alan Walts
Venture Partner at Advent Life Sciences
Andrea Beesley
Team Assistant at Advent Life Sciences
Bonita Theara
Executive Assistant at Advent Life Sciences
Dominic Schmidt
General Partner at Advent Life Sciences
Don Drakeman
Distinguished Research Professor, biotech entrepreneur, and venture partner
Fraser Murray
Head of Scientific Evaluation at Advent Life Sciences
Gail Jermyn
Investor Relations Partner at Advent Life Sciences
Frequently asked questions
- Who is Jon Moore?
- Jon Moore joined Advent Life Sciences in 2018, bringing over two decades of experience at UK biotech companies, including a role as CSO of Horizon Discovery. His background covers early-stage drug discovery against first-in-class targets, gene editing applied to drug discovery, and therapeutic platform development. Since joining Advent he has focused on new company creation, serving as founding CEO of Pheno Therapeutics and currently as founding CEO of cancer immuno-therapeutics company Epitopea.
- Where does Jon Moore work?
- Jon Moore is Operating Partner at Advent Life Sciences.
- What does Jon Moore invest in?
- Jon Moore invests in Biotech.
- What companies has Jon Moore invested in?
- Investments tracked here include Epitopea, Pheno Therapeutics.